NEW YORK–(BUSINESS WIRE)–IVERIC bio today reported that the Company granted newly hired employees equity-based awards.
Author: Business Wire
Global Retinal Disorder Treatment Market Analysis & Forecast to 2027 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Retinal Disorder Treatment Market; Dosage Form – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 – 2027” report has been added to ResearchAndMarkets.com’s offering. Retinal Disorder Treatment Mark…
Company Profile for Kubota Vision Inc. (dba of Acucela Inc.)
–(BUSINESS WIRE)–Kubota Vision Inc. is a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596) committed to translating innovation into a diverse portfolio of drugs and devices to preserve and restore vision for millions of…
Ophthalmology Times® Is Now Accepting Nominations for the 2020 Resident Writer’s Award Program
CRANBURY, N.J.–(BUSINESS WIRE)– #WritingProgram–Nominations must be submitted electronically on or before April 27, 2020, for consideration in this year’s program.
Notice Regarding Business Alliance Between Sanbio and Ocumension in the Research, Development and Commercialization of Innovative Stem Cell Therapies for Ophthalmic Diseases
TOKYO–(BUSINESS WIRE)–Notice Regarding Business Alliance In The Research, Development And Commercialization Of Innovative Stem Cell Therapies For Ophthalmic Diseases.
TEPEZZA™ (teprotumumab-trbw) Significantly Reduces Proptosis (Eye Bulging), a Key Marker of Thyroid Eye Disease, Across Patient Subtypes
DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics announces new pooled efficacy data for TEPEZZA (teprotumumab-trbw) for the treatment of Thyroid Eye Disease (TED).
Wolters Kluwer’s Simplifi 797 and VeriForm Included on GSA
WALTHAM, Mass.–(BUSINESS WIRE)– #CDSupport–Wolters Kluwer’s Simplifi 797® and VeriForm® solutions have been approved for inclusion on the U.S. General Services Administration (GSA)
Second Sight Announces Employee Layoffs, Intent to Wind Down Operations and Appointment of Matthew Pfeffer as Acting CEO
LOS ANGELES–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or the “Company”), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision…
FDA Approves Next-Generation ZOLL® TherOx System for Widowmaker Heart Attack Patients
CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei Group company that manufactures medical devices and related software solutions, announced today it has received U.S. Food and Drug Administration (FDA) approval of the second…
Global Eye Health Ingredients Market (2018 to 2025) – Demand for a Different Variety of Ingredients Presents Opportunities – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Eye Health Ingredients Market By Source, By Ingredient, By Form, By Application, and By Disease Indication: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018 – 2025” report has been added to ResearchA…
ICU Eyewear and Contour Optik Heed the Call and Expand Production Capacity to Hundreds of Millions of PPE and COVID-19 Test Kits
HOLLISTER, Calif.–(BUSINESS WIRE)–ICU Eyewear and Contour Optik expand production capacity to produce hundreds of millions of PPE and COVID-19 test kits
National Vision Provides COVID-19 Related Business Update
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”), one of the nation’s largest optical retailers providing quality, affordable eye care and eyewear, today announced that it has extended the …
Global Optic Neuropathy Pipeline Guide 2020 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Optic Neuropathy – Pipeline Review, H1 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering. This pipeline guide, Optic Neuropathy – Pipeline Review, H1 2020 provides comprehensive information on the th…
Juvenile Macular Degeneration (Stargardt Disease) Pipeline Review, H1 2020 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Juvenile Macular Degeneration (Stargardt Disease) Pipeline Review, H1 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering. This pipeline guide Juvenile Macular Degeneration (Stargardt Disease) Pipeline…
NovaBay Pharmaceuticals Reports 2019 Fourth Quarter and Full Year Financial Results
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova® for the domestic eye care market, reports financial results for the three and 12 months ended Dec…
How Walmart and Sam's Club Are Helping Small Business Partners
BENTONVILLE, Ark.–(BUSINESS WIRE)–The following is a statement from John Furner, President & CEO – Walmart U.S. and Kath McLay, President & CEO – Sam’s Club: Walmart and Sam’s Club are central to thousands of American communities, and we serv…
Blepharitis Pipeline Review, H1 2020 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Blepharitis Pipeline Review, H1 2020” drug pipelines has been added to ResearchAndMarkets.com’s offering. Blepharitis Pipeline Review, H1 2020, provides comprehensive information on the therapeutics under development for B…
Glaukos Provides COVID-19 Pandemic Update
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retina diseases, today provided an upda…
IVERIC bio Appoints Pravin U. Dugel, MD, as Executive Vice President and Chief Strategy and Business Officer
NEW YORK–(BUSINESS WIRE)–IVERIC bio, Inc. announced the appointment of Pravin U. Dugel, MD, as Executive Vice President and Chief Strategy and Business Officer.
EyeCare Services Partners Designates Regional Offices to Remain Open for Urgent and Emergency Ophthalmic or Optical Services
DALLAS–(BUSINESS WIRE)–Urgent and emergency ophthalmology and optical services available in California, Colorado, Delaware, Florida, Illinois, Maryland